$TARS 3 SEC Filings

Filed On	Filing
20 Feb 2026	Form 3: Pyott David E I, Director Holds 7,991 shares of Common Stock
15 Nov 2024	Form 3: Goodrich Katherine, Director No securities owned
26 Apr 2023	Form 3: Farrow Jeffrey S, See Remarks No securities owned
11 Oct 2022	Form 3: Morrison Scott W, Director No securities owned
03 Feb 2022	Form 3: Trevejo Jose M., CHIEF MEDICAL OFFICER No securities owned
04 Jan 2022	Form 3: Lin Elizabeth Yeu, Director
12 Aug 2021	Form 3: Crane Rosemary A, Director No securities owned
21 Jan 2021	Form 3: Wahl Bryan, General Counsel Holds 5,000 shares of Common Stock
08 Jan 2021	Form 3: Whitfield Dianne C., Chief Human Resources Officer No securities owned
23 Nov 2020	Form 3: Yarno Wendy L, Director No securities owned
26 Oct 2020	Form 3: Rtw INVESTMENTS, Lp, 10% owner and 1 other Holds 2,463,601 shares of Common Stock
15 Oct 2020	Form 3: Frazier Life Sciences IX, L.p., 10% owner and 4 others
15 Oct 2020	Form 3: Horowitz Limited Partnership Viii, 10% owner
15 Oct 2020	Form 3: Vivo Capital IX, Llc, 10% owner and 1 other
15 Oct 2020	Form 3: Link William J Phd, Director Holds 134,632 shares of Common Stock
15 Oct 2020	Form 3: Tester Jason E., Director
15 Oct 2020	Form 3: Chaudhuri Bhaskar, Director No securities owned
15 Oct 2020	Form 3: Goldberg Andrew D., Director No securities owned
15 Oct 2020	Form 3: Ackermann Michael, Director Holds 1,165,739 shares of Common Stock
15 Oct 2020	Form 3: Holdbrook Mark J., V.P., Clinical Affairs

Comments